Results 251 to 260 of about 1,013,409 (339)

Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination

open access: bronze, 1994
Marina Cavazzana   +8 more
openalex   +1 more source

Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era

open access: yesTransplantation, 2013
P. Thurairajah   +7 more
semanticscholar   +1 more source

Cardioprotective effects of semaglutide on isolated human ventricular myocardium

open access: yesEuropean Journal of Heart Failure, EarlyView.
Semaglutide reduces late sodium current (INa) and diastolic calcium (Ca) sparks in human cardiomyocytes from aortic stenosis (AS) and end‐stage heart failure with reduced ejection fraction (HFrEF) patients, thereby increasing Ca transients. Improved Ca storage may underly the enhanced contractility of human cardiomyocytes upon semaglutide.
Thomas Krammer   +16 more
wiley   +1 more source

EVIDENCE THAT DRUG-RESISTANT ALLOREACTIVE T CELLS MAY CONTRIBUTE TO HUMAN GRAFT REJECTION

open access: bronze, 1990
William L. Stanford   +2 more
openalex   +1 more source

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT‐HF): Baseline characteristics compared to recent randomized controlled heart failure trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Effects of digitoxin compared to placebo on efficacy and safety in patients with heart failure and reduced ejection fraction (HFrEF). Primary endpoint: time to all‐cause death and first hospitalization for worsening heart failure (whatever occurs first). ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin
Udo Bavendiek   +35 more
wiley   +1 more source

Exploring personalized treatment for cardiac graft rejection based on a four-archetype analysis model and bioinformatics analysis. [PDF]

open access: yesSci Rep
Shi H   +12 more
europepmc   +1 more source

Tetrazolium vital staining for early detection of corneal graft rejection

open access: gold, 1992
Istiantoro Sukardi   +2 more
openalex   +2 more sources

Cardio‐microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C‐MIC II open‐label randomized controlled trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Efficacy and Safety of C‐MIC Device in Patients with Heart Failure with Reduced Ejection Fraction. 6MWD, 6‐min walk distance; CI, confidence interval; KCCQ‐OSS, Kansas City Cardiomyopathy Questionnaire overall summary score; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.
Jesus E. Rame   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy